PlainPharmaWatch

CMS Open Payments · Program Year 2024

Rayner Intraocular Lenses Limited

Rayner Intraocular Lenses Limited reported $421,731.65 across General Payments, Research, and Ownership to 2,145 physicians and teaching hospitals across 2,162 transactions.

See the rankings → How this is sourced
$421.7K
All-tracks total
2,162
Transactions
2,145
Recipients
+$26.3K
General Payments vs PY2023

Rayner Intraocular Lenses Limited reported $421,731.65 across all CMS Open Payments tracks (General + Research + Ownership) to 2,145 physicians and teaching hospitals in Program Year 2024 - ranking #805 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $262,704.15, averaging $196.61 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer rayner-intraocular-lenses-limited Rayner Intraocular Lenses Limited

$421.7K · #805/1,925 · 0.0% industry · PY2024

  • TOT $421.7K
  • RANK #805
  • SHARE 0.0%
  • TXN 2,162
  • RCP 2,145
  • CAT 5
  • GEN $262.7K
  • ΔGEN +$26.3K
  • TOP1 26.4%
  • PY 2024

Volume peers

Nearest volume peer: Almatica Pharma LLC ($421.9K)

Cepheid$423.4KAlmatica Pharma LLC$421.9KRayner Intraocular Lenses Li…$421.7KBio-Rad Laboratories, Inc.$421.2KCeQur Corporation$420.1K
All-tracks payment totals near Rayner Intraocular Lenses Limited (CMS Open Payments PY2024)

Rayner Intraocular Lenses Limited sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Rayner Intraocular Lenses Limited's CMS-reported General Payments increased by $26.3K (+11.1%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: RAYNER INTRAOCULAR LENSES LIMITEDPY2023: RAYNER INTRAOCULAR LENSES LIMITEDPY2024: Rayner Intraocular Lenses Limited. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$236.4KPY2024$262.7K
PY2023
$236,367.25
PY2024
$262,704.15

What the Data Shows for Rayner Intraocular Lenses Limited

$421,731.65: that is what Rayner Intraocular Lenses Limited reported in payments to 2,145 physicians and teaching hospitals during Program Year 2024, spread across 2,162 transactions ($195.07 per transaction, $196.61 per recipient). The company sits at rank #805 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 5 general-payment categories charted below, "Consulting Fee" is the largest at $98.1K across 29 transactions, 37.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 5 types of general payments, Rayner Intraocular Lenses Limited's largest category was "Consulting Fee" at $98.1K - 37.3% of General Payments.

Rayner Intraocular Lenses Limited reports 5 general-payment categories - the top three are Consulting Fee (37.3%), Compensation for Services Other Than Consulting (34.6%), and Food and Beverage (23.1%). The remaining 2 categories make up 4.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How Rayner Intraocular Lenses Limited divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$98.1K2. Compensation for Services…$90.9K3. Food and Beverage$60.7K4. Grant$7.5K5. Travel and Lodging$5.4K
Payment Type Amount Transactions
Consulting Fee $98.1K 29
Compensation for Services Other Than Consulting $90.9K 19
Food and Beverage $60.7K 2,077
Grant $7.5K 1
Travel and Lodging $5.4K 19

Recipient Concentration in General Payments

The five largest recipient relationships account for $140,121.05 (53.3%) of $262,704.15 in this company's General Payments records across 1,437 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Rayner Intraocular Lenses Limited

The five named recipients with the highest reported General Payments from this company

Brett Bielory$69.2KDavid Goldman$26.4KSara Butterworth$18.5KRajen U Desai$13.3KMichael Alterman$12.7K
  1. 1

    Brett Bielory

    $69,243.94 across 38 reported transactions

  2. 2

    David Goldman

    $26,362.83 across 15 reported transactions

  3. 3

    Sara Butterworth

    $18,462.50 across 2 reported transactions

  4. 4

    Rajen U Desai

    $13,329.25 across 6 reported transactions

  5. 5

    Michael Alterman

    $12,722.53 across 8 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Rayner Intraocular Lenses Limited's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Rayner Intraocular Lenses Limited.

PARI Respiratory Equipment, Inc.

HHI 954

Spinefrontier, Inc.

HHI 958

BioXcel Therapeutics, Inc.

HHI 958

STRATA Skin Sciences, Inc.

HHI 940

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Rayner Intraocular Lenses Limited.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Rayner Intraocular Lenses Limited's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.